English   español  

Browsing by Author Mateos, Maria Victoria

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 74  next >
RightsPreviewIssue DateTitleAuthor(s)Type
closedAccessaccesoRestringido.pdf.jpg2013A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease controlPaiva, Bruno; Vidriales, Maria Belén; Martínez-López, Joaquín; Mateos, Maria Victoria; Ocio, Enrique M.  ; Gutiérrez, Norma Carmen; Díaz-Mediavilla, J.; Orfao, Alberto  ; Lahuerta, Juan José; Bladé, Joan; San Miguel, Jesús F. artículo
openAccessnovelnano.pdf.jpg2018A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: Biological and clinical utilityMisiewicz-Krzeminska, Irena; Corchete, Luis A.; Rojas, Elizabeta A.; Martínez-López, Joaquín; García-Sanz, Ramón; Oriol, Albert; Bladé, Joan; Lahuerta, Juan José; San Miguel, Jesús F. ; Mateos, Maria Victoria; Gutiérrez, Norma Carmenartículo
closedAccessaccesoRestringido.pdf.jpg2017A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myelomaLaubach, Jacob P.; Moslehi, Javid J.; Francis, Sanjeev A.; San Miguel, Jesús F. ; Sonneveld, Pieter; Orlowski, R. Z.; Moreau, Philippe; Rosiñol, Laura; Faber Jr., Edward A.; Voorhees, Peter; Mateos, Maria Victoria; Marquez, Loreta; Feng, Huaibao; Desai, Avinash; Velde, Helgi van de; Elliott, Jennifer; Shi, Hongliang; Dow, Edward; Jobanputra, Nishith; Esseltine, Dixie-Lee; Niculescu, Liviu; Anderson, Kenneth; Lonial, Sagar; Richardson, Paul G.artículo
closedAccessaccesoRestringido.pdf.jpg2017Absence of spontaneous response improvement beyond day +100 after autologous stem cell transplantation in multiple myelomaFernández de Larrea, Carlos; Dávila, Julio; Isola, I.; Ocio, Enrique M.  ; Rosiñol, Laura; García-Sanz, Ramón; Cibeira, M.T.; Tovar, N.; Rovira, M.; Mateos, Maria Victoria; Miguel, J. S.; Bladé, Joanartículo
openAccess4 randomized trials.pdf.jpg2013Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trialsBringhen, Sara; Mateos, Maria Victoria; Lahuerta, Juan José; San Miguel, Jesús F. ; Palumbo, Antonioartículo
closedAccessaccesoRestringido.pdf.jpg2017Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myelomaRojas, Elizabeta A.; Corchete, Luis A.; San-Segundo, Laura; Martínez-Blanch, Juan F.; Codoñer, Francisco M.; Paíno, Teresa ; Puig, Noemi; García-Sanz, Ramón; Mateos, Maria Victoria; Ocio, Enrique M.  ; Misiewicz-Krzeminska, Irena; Gutiérrez, Norma Carmenartículo
openAccessflowcytometry.pdf.jpg2013Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometryPessoa de Magalhães, Roberto J.; Vidriales, Maria Belén; Paiva, Bruno; Fernández, Carlos; García-Sanz, Ramón; Mateos, Maria Victoria; Gutiérrez, Norma Carmen; Lécrevisse, Quentin; Blanco, Juan F.; Martínez-López, Joaquín; Sobral da Costa, E.; Ocio, Enrique M.  ; Pérez-Andrés, Martin; Lahuerta, Juan José; San Miguel, Jesús F. ; Orfao, Alberto  artículo
closedAccessaccesoRestringido.pdf.jpg2010BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)Santamaría, Carlos; Chillón, M. del Carmen; García-Sanz, Ramón; Caballero, Maria Dolores; Mateos, Maria Victoria; Sarasquete, María Eugenia; Díaz-Mediavilla, J.; San Miguel, Jesús F. ; González, Marcos  artículo
closedAccessaccesoRestringido.pdf.jpg2014Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapyMateos, Maria Victoria; Bringhen, Sara; Richardson, Paul G.; Lahuerta, Juan José; García-Sanz, Ramón; San Miguel, Jesús F. ; Palumbo, Antonioartículo
closedAccessaccesoRestringido.pdf.jpg2007Bortezomib in multiple myelomaMateos, Maria Victoria; San Miguel, Jesús F. artículo
closedAccessaccesoRestringido.pdf.jpg2011Bortezomib in the upfront treatment of multiple MyelomaSan Miguel, Jesús F. ; Mateos, Maria Victoriacapítulo de libro
openAccessBortezomib Plus Melphalan.pdf.jpg2010Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA TrialMateos, Maria Victoria; San Miguel, Jesús F. artículo
openAccessBortezomib plus.pdf.jpg2008Bortezomib plus melphalan and prednisone for initial treatment of multiple myelomaSan Miguel, Jesús F. ; Mateos, Maria Victoriaartículo
closedAccessaccesoRestringido.pdf.jpg2014Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched studyMorabito, Fortunato; Bringhen, Sara; Mateos, Maria Victoria; Lahuerta, Juan José; San Miguel, Jesús F. ; Palumbo, Antonioartículo
openAccess10.3324-haematol.2010.028027.pdf.jpg1-Nov-2010Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 studyLahuerta, Juan José; Mateos, Maria Victoria; San Miguel, Jesús F. artículo
openAccessCan multiple myeloma.pdf.jpg2011Can multiple myeloma become a curable disease?San Miguel, Jesús F. ; Mateos, Maria Victoriaartículo
closedAccessaccesoRestringido.pdf.jpg2011Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating agents: Analysis of the VISTA trialRichardson, Paul G.; Mateos, Maria Victoria; San Miguel, Jesús F. artículo
closedAccessaccesoRestringido.pdf.jpg2013Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA studyMartínez-López, Joaquín; García-Sanz, Ramón; Paiva, Bruno; Mateos, Maria Victoria; Sarasquete, María Eugenia; Bladé, Joan; San Miguel, Jesús F. ; Lahuerta, Juan Joséartículo
closedAccessaccesoRestringido.pdf.jpg2016Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myelomaDonk, Niels W. C. J. van de; Moreau, Philippe; Plesner, Torben; Palumbo, Antonio; Gay, Francesca; Laubach, Jacob P.; Malavasi, Fabio; Avet-Loiseau, Hervé; Mateos, Maria Victoria; Sonneveld, Pieter; Lokhorst, Henk M.; Richardson, Paul G.artículo
closedAccessaccesoRestringido.pdf.jpg2012Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patientsPaiva, Bruno; Gutiérrez, Norma Carmen; Chen, Xi ; Vidriales, Maria Belén; Martínez-López, Joaquín; Mateos, Maria Victoria; López-Corral, L.; Díaz-Rodríguez, Elena ; Orfao, Alberto  ; Lahuerta, Juan José; Bladé, Joan; Pandiella, Atanasio  ; San Miguel, Jesús F. artículo